Health Condition 1: null- Diabetic
Conditions
Interventions
Intervention1: Human Insulin: to prepare Indiaâ??s largest human insulin registry to
understand, knowledge, attitude and practice (KAP) of early initiation of human
insulins by clinicians in India
Sponsors
Biocon Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. As per the package insert 2. Diagnosed with DM and as per physicianâ??s assessment requires initiation of human insulin for treatment 3. Insulin naïve patients with DM or patients who are on insulin analogues 4. Patient agrees to sign patient Informed Consent Form (ICF)
Exclusion criteria
Exclusion criteria: 1. Preferably avoid pregnant women and who desire to become pregnant during study period as per the history given by patients 2. Patients who are hypersensitive to human insulin or the excipients 3. Patients who are/was on human insulin therapy 4. Patients participating in a clinical trial of an investigational drug in the 3 months prior to first visit (part 1), or within 5 half-lives of an investigational drug at first visit (whichever is longer), or scheduled for another investigational drug during the current study period. 5. As per the discretion of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to prepare Indiaâ??s largest human insulin registry to understand, knowledge, attitude and practice (KAP) of early initiation of human insulins by clinicians in IndiaTimepoint: After completion of 6th month follow up after starting from patientâ??s first visit to the doctor to the follow up call to the patient which he/she will receive till 6th month. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of the adherence of patients to human insulin therapy 2. Evaluation of treatment satisfaction of patients receiving human insulin therapy through Diabetes Treatment Satisfaction Questionnaire status version (DTSQs)Timepoint: 6th month follow up starting from patientâ??s first visit to the doctor to the follow up call to the patient which he/she will receive till 6th month. | — |
Countries
India
Contacts
Public ContactDr Prameela Rani
Clinsync clinical research Pvt. Ltd.
Outcome results
None listed